POTENTIAL TARGETS FROM HUMAN (RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES)1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Seq. Identity (%)	View	Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1LHV_A_NOGA301_1 (SEX HORMONE-BINDING GLOBULIN)	1aoa	T-FIMBRIN (Homo sapiens)	4 / 8	THR A 354 ASP A 357 PHE A 352 ASN A 362	THR  A 354 ( 0.8A) ASP  A 357 ( 0.6A) PHE  A 352 ( 1.3A) ASN  A 362 ( 0.6A)	0.97A	23.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1LHV_A_NOGA301_1 (SEX HORMONE-BINDING GLOBULIN)	1i4e	CASPASE-8 (Homo sapiens)	4 / 8	THR B2405 ASN B2408 MET B2403 LEU B2401	None	1.11A	21.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1LHV_A_NOGA301_1 (SEX HORMONE-BINDING GLOBULIN)	1lhu	SEX HORMONE-BINDING GLOBULIN (Homo sapiens)	8 / 8	SER A  42 THR A  60 ASP A  65 PHE A  67 ASN A  82 MET A 107 MET A 139 LEU A 171	EST  A 301 (-2.7A) None EST  A 301 (-2.9A) EST  A 301 (-4.0A) EST  A 301 (-3.9A) EST  A 301 ( 3.9A) EST  A 301 ( 3.9A) None	0.62A	100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1LHV_A_NOGA301_1 (SEX HORMONE-BINDING GLOBULIN)	1tzs	CATHEPSIN E (Homo sapiens)	4 / 8	SER A 299 ASN A  19 MET A  23 LEU A 288	None	0.95A	21.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1LHV_A_NOGA301_1 (SEX HORMONE-BINDING GLOBULIN)	2nvu	MALTOSE BINDING PROTEIN/NEDD8-ACTIVA TING ENZYME E1 CATALYTIC SUBUNIT CHIMERA (Homo sapiens)	4 / 8	SER B1256 THR B1226 ASN B1151 LEU B1248	None	0.96A	12.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1LHV_A_NOGA301_1 (SEX HORMONE-BINDING GLOBULIN)	2qp4	BILE SALT SULFOTRANSFERASE (Homo sapiens)	4 / 8	SER A  98 ASP A  28 PHE A  30 LEU A 100	None	0.95A	22.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1LHV_A_NOGA301_1 (SEX HORMONE-BINDING GLOBULIN)	3b2d	CD180 ANTIGEN (Homo sapiens)	4 / 8	SER A 120 PHE A 142 ASN A 159 LEU A 121	None	1.05A	14.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1LHV_A_NOGA301_1 (SEX HORMONE-BINDING GLOBULIN)	3btz	ALPHA-KETOGLUTARATE- DEPENDENT DIOXYGENASE ALKB HOMOLOG 2 (Homo sapiens)	4 / 8	SER A 182 ASN A 250 MET A 226 LEU A 178	None	1.00A	20.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1LHV_A_NOGA301_1 (SEX HORMONE-BINDING GLOBULIN)	3n93	MALTOSE BINDING PROTEIN-CRFR2 ALPHA (Homo sapiens)	4 / 8	SER A-115 THR A-145 ASN A-220 LEU A-123	None	1.00A	16.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1LHV_A_NOGA301_1 (SEX HORMONE-BINDING GLOBULIN)	3zwf	ZINC PHOSPHODIESTERASE ELAC PROTEIN 1 (Homo sapiens)	4 / 8	SER A  79 THR A 106 MET A 107 LEU A 114	None	0.80A	19.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1LHV_A_NOGA301_1 (SEX HORMONE-BINDING GLOBULIN)	4db1	MYOSIN-7 (Homo sapiens)	4 / 8	SER A 173 THR A 481 ASN A 654 LEU A 175	None	1.00A	12.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1LHV_A_NOGA301_1 (SEX HORMONE-BINDING GLOBULIN)	5edu	MALTOSE-BINDING PERIPLASMIC PROTEIN, HISTONE DEACETYLASE 6 CHIMERA (Escherichia coli; Homo sapiens)	4 / 8	SER B 363 THR B 333 ASN B 258 LEU B 355	None	1.07A	14.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1LHV_A_NOGA301_1 (SEX HORMONE-BINDING GLOBULIN)	5hyd	PROTEIN S100-Z (Homo sapiens)	4 / 8	ASP A  71 PHE A  75 ASN A  73 LEU A  62	None	1.12A	19.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1LHV_A_NOGA301_1 (SEX HORMONE-BINDING GLOBULIN)	5hzv	MALTOSE-BINDING PERIPLASMIC PROTEIN,ENDOGLIN (Escherichia coli; Homo sapiens)	4 / 8	SER A 622 THR A 592 ASN A 517 LEU A 614	None	1.07A	16.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1LHV_A_NOGA301_1 (SEX HORMONE-BINDING GLOBULIN)	5hzw	MALTOSE-BINDING PERIPLASMIC PROTEIN,ENDOGLIN (Escherichia coli; Homo sapiens)	4 / 8	SER A 310 THR A 280 ASN A 205 LEU A 302	None	1.05A	15.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1LHV_A_NOGA301_1 (SEX HORMONE-BINDING GLOBULIN)	5jcg	THIOREDOXIN-DEPENDEN T PEROXIDE REDUCTASE, MITOCHONDRIAL (Homo sapiens)	4 / 8	ASP A  56 PHE A  54 MET A  95 LEU A  99	None	0.97A	22.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D90_A_NOGA1001_1 (PROGESTERONE RECEPTOR)	1xb7	STEROID HORMONE RECEPTOR ERR1 (Homo sapiens)	5 / 12	LEU A 324 LEU A 327 MET A 362 ARG A 372 LEU A 401	None	0.63A	26.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3D90_A_NOGA1001_1 (PROGESTERONE RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	8 / 12	LEU A 701 LEU A 704 ASN A 705 LEU A 707 GLN A 711 MET A 742 MET A 745 ARG A 752	None BHM  A   1 (-4.0A) BHM  A   1 (-3.6A) BHM  A   1 ( 4.2A) BHM  A   1 (-2.2A) BHM  A   1 ( 4.0A) BHM  A   1 (-3.9A) BHM  A   1 (-3.8A)	0.60A	54.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3D90_A_NOGA1001_1 (PROGESTERONE RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	8 / 12	LEU A 701 LEU A 704 LEU A 707 GLN A 711 MET A 742 MET A 745 ARG A 752 MET A 787	None BHM  A   1 (-4.0A) BHM  A   1 ( 4.2A) BHM  A   1 (-2.2A) BHM  A   1 ( 4.0A) BHM  A   1 (-3.9A) BHM  A   1 (-3.8A) BHM  A   1 (-3.6A)	0.77A	54.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D90_A_NOGA1001_1 (PROGESTERONE RECEPTOR)	2gpv	ESTROGEN-RELATED RECEPTOR GAMMA (Homo sapiens)	6 / 12	LEU A 265 LEU A 268 LEU A 271 MET A 306 ARG A 316 LEU A 345	None OHT  A 500 (-4.1A) OHT  A 500 ( 4.4A) OHT  A 500 (-3.9A) OHT  A 500 (-3.8A) OHT  A 500 (-4.3A)	0.46A	28.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D90_A_NOGA1001_1 (PROGESTERONE RECEPTOR)	2h2m	COMM DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	5 / 12	LEU A  16 ASN A  17 LEU A  19 ARG A  49 LEU A  72	None	1.22A	16.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D90_A_NOGA1001_1 (PROGESTERONE RECEPTOR)	3eap	RHO GTPASE-ACTIVATING PROTEIN 11A (Homo sapiens)	5 / 12	LEU A  15 LEU A  12 LEU A   9 LEU A 137 CYH A 161	None	1.21A	22.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3D90_A_NOGA1001_1 (PROGESTERONE RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	10 / 12	LEU A 715 LEU A 718 ASN A 719 LEU A 721 GLN A 725 MET A 756 MET A 759 ARG A 766 MET A 801 CYH A 891	WOW  A   1 (-3.9A) WOW  A   1 (-4.2A) WOW  A   1 (-3.3A) WOW  A   1 ( 4.3A) WOW  A   1 ( 4.1A) WOW  A   1 ( 4.1A) WOW  A   1 (-3.7A) WOW  A   1 (-3.8A) WOW  A   1 (-4.2A) WOW  A   1 (-3.5A)	0.53A	100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3D90_A_NOGA1001_1 (PROGESTERONE RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	10 / 12	LEU A 715 LEU A 718 ASN A 719 LEU A 721 MET A 756 MET A 759 ARG A 766 MET A 801 TYR A 890 CYH A 891	WOW  A   1 (-3.9A) WOW  A   1 (-4.2A) WOW  A   1 (-3.3A) WOW  A   1 ( 4.3A) WOW  A   1 ( 4.1A) WOW  A   1 (-3.7A) WOW  A   1 (-3.8A) WOW  A   1 (-4.2A) WOW  A   1 (-3.9A) WOW  A   1 (-3.5A)	0.40A	100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3D90_A_NOGA1001_1 (PROGESTERONE RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	5 / 12	LEU A 721 LEU A 718 LEU A 715 LEU A 763 MET A 801	WOW  A   1 ( 4.3A) WOW  A   1 (-4.2A) WOW  A   1 (-3.9A) WOW  A   1 ( 4.0A) WOW  A   1 (-4.2A)	1.15A	100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D90_A_NOGA1001_1 (PROGESTERONE RECEPTOR)	3kn5	RIBOSOMAL PROTEIN S6 KINASE ALPHA-5 (Homo sapiens)	5 / 12	LEU A 676 LEU A 667 LEU A 668 LEU A 687 MET A 525	None	1.33A	22.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D90_A_NOGA1001_1 (PROGESTERONE RECEPTOR)	4b99	MITOGEN-ACTIVATED PROTEIN KINASE 7 (Homo sapiens)	5 / 12	LEU A 166 ASN A 113 LEU A 167 LEU A 144 MET A 255	None	1.29A	20.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D90_A_NOGA1001_1 (PROGESTERONE RECEPTOR)	4ez5	CYCLIN-DEPENDENT KINASE 6 (Homo sapiens)	5 / 12	LEU A 129 ASN A  75 LEU A 130 LEU A 105 MET A 212	None	1.33A	18.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D90_A_NOGA1001_1 (PROGESTERONE RECEPTOR)	4fdh	CYTOCHROME P450 11B2, MITOCHONDRIAL (Homo sapiens)	5 / 12	LEU A 324 LEU A 327 GLN A 337 ARG A 341 LEU A 186	None	1.32A	19.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D90_A_NOGA1001_1 (PROGESTERONE RECEPTOR)	4fdh	CYTOCHROME P450 11B2, MITOCHONDRIAL (Homo sapiens)	5 / 12	LEU A 324 LEU A 327 LEU A 330 GLN A 337 ARG A 341	None	1.17A	19.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D90_A_NOGA1001_1 (PROGESTERONE RECEPTOR)	4ol0	TRANSPORTIN-3 (Homo sapiens)	5 / 12	LEU B   8 LEU B  50 LEU B  51 MET B  67 LEU B  37	None	1.41A	14.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3D90_A_NOGA1001_1 (PROGESTERONE RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	7 / 12	ASN A 564 GLN A 570 MET A 601 ARG A 611 MET A 646 TYR A 735 CYH A 736	MOF  A 801 (-3.0A) MOF  A 801 (-2.9A) MOF  A 801 (-3.7A) MOF  A 801 (-4.2A) MOF  A 801 (-4.4A) MOF  A 801 (-4.8A) MOF  A 801 (-3.7A)	0.72A	54.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3D90_A_NOGA1001_1 (PROGESTERONE RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	8 / 12	LEU A 563 ASN A 564 LEU A 566 GLN A 570 MET A 601 ARG A 611 MET A 646 CYH A 736	MOF  A 801 (-3.9A) MOF  A 801 (-3.0A) MOF  A 801 ( 4.6A) MOF  A 801 (-2.9A) MOF  A 801 (-3.7A) MOF  A 801 (-4.2A) MOF  A 801 (-4.4A) MOF  A 801 (-3.7A)	0.68A	54.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3D90_A_NOGA1001_1 (PROGESTERONE RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	8 / 12	LEU A 563 ASN A 564 LEU A 566 GLN A 570 MET A 601 MET A 604 ARG A 611 MET A 646	MOF  A 801 (-3.9A) MOF  A 801 (-3.0A) MOF  A 801 ( 4.6A) MOF  A 801 (-2.9A) MOF  A 801 (-3.7A) None MOF  A 801 (-4.2A) MOF  A 801 (-4.4A)	0.94A	54.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3D90_A_NOGA1001_1 (PROGESTERONE RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	5 / 12	LEU A 566 LEU A 563 MET A 639 LEU A 608 MET A 646	MOF  A 801 ( 4.6A) MOF  A 801 (-3.9A) MOF  A 801 (-3.7A) MOF  A 801 ( 4.6A) MOF  A 801 (-4.4A)	1.32A	54.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D90_A_NOGA1001_1 (PROGESTERONE RECEPTOR)	4u1a	ENOYL-COA DELTA ISOMERASE 2 (Homo sapiens)	5 / 12	LEU A 188 LEU A 189 ASN A 185 LEU A 336 GLN A 242	CL  A 401 ( 4.9A) CL  A 401 ( 4.4A) CL  A 401 ( 4.2A) None None	1.26A	19.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3D90_A_NOGA1001_1 (PROGESTERONE RECEPTOR)	4udb	MINERALOCORTICOID RECEPTOR (Homo sapiens)	6 / 12	LEU A 766 ASN A 770 MET A 807 ARG A 817 LEU A 848 CYH A 942	CV7  A1987 (-3.6A) CV7  A1987 (-3.1A) CV7  A1987 ( 3.9A) CV7  A1987 (-3.7A) CV7  A1987 ( 4.4A) CV7  A1987 (-4.0A)	0.82A	52.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3D90_A_NOGA1001_1 (PROGESTERONE RECEPTOR)	4udb	MINERALOCORTICOID RECEPTOR (Homo sapiens)	9 / 12	LEU A 766 LEU A 769 ASN A 770 LEU A 772 GLN A 776 MET A 807 ARG A 817 MET A 852 CYH A 942	CV7  A1987 (-3.6A) CV7  A1987 (-4.1A) CV7  A1987 (-3.1A) CV7  A1987 ( 4.5A) CV7  A1987 (-3.0A) CV7  A1987 ( 3.9A) CV7  A1987 (-3.7A) CV7  A1987 ( 3.7A) CV7  A1987 (-4.0A)	0.59A	52.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3D90_A_NOGA1001_1 (PROGESTERONE RECEPTOR)	4udb	MINERALOCORTICOID RECEPTOR (Homo sapiens)	5 / 12	LEU A 772 LEU A 769 LEU A 766 LEU A 814 MET A 852	CV7  A1987 ( 4.5A) CV7  A1987 (-4.1A) CV7  A1987 (-3.6A) CV7  A1987 ( 4.0A) CV7  A1987 ( 3.7A)	1.27A	52.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D90_A_NOGA1001_1 (PROGESTERONE RECEPTOR)	4y6o	NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-2 (Homo sapiens)	5 / 12	LEU A 335 LEU A 329 GLN A 326 LEU A 258 MET A 260	None	1.26A	24.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D90_A_NOGA1001_1 (PROGESTERONE RECEPTOR)	5cqr	ELONGATOR COMPLEX PROTEIN 1 (Homo sapiens)	5 / 12	LEU A 918 LEU A 921 ASN A 922 LEU A 924 GLN A 932	None	0.90A	18.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D90_A_NOGA1001_1 (PROGESTERONE RECEPTOR)	5dot	CARBAMOYL-PHOSPHATE SYNTHASE [AMMONIA], MITOCHONDRIAL (Homo sapiens)	5 / 12	LEU A 526 LEU A 520 GLN A 490 LEU A 426 MET A 462	None	1.46A	10.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D90_A_NOGA1001_1 (PROGESTERONE RECEPTOR)	5gs0	TOLL-LIKE RECEPTOR 3 (Homo sapiens)	5 / 12	LEU A 386 LEU A 412 ASN A 413 LEU A 436 LEU A 381	None None NAG  A 814 (-2.6A) None None	1.41A	18.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D90_A_NOGA1001_1 (PROGESTERONE RECEPTOR)	5gs0	TOLL-LIKE RECEPTOR 3 (Homo sapiens)	5 / 12	LEU A 386 LEU A 414 ASN A 413 LEU A 438 LEU A 404	None None NAG  A 814 (-2.6A) None None	1.29A	18.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D90_A_NOGA1001_1 (PROGESTERONE RECEPTOR)	5hdh	TOLL-LIKE RECEPTOR 8 (Homo sapiens)	5 / 12	LEU A 253 LEU A 294 LEU A 318 LEU A 289 MET A 310	None	1.47A	16.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D90_A_NOGA1001_1 (PROGESTERONE RECEPTOR)	5hdh	TOLL-LIKE RECEPTOR 8 (Homo sapiens)	5 / 12	LEU A 542 LEU A 561 ASN A 564 LEU A 591 LEU A 535	None	1.37A	16.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3D90_A_NOGA1001_1 (PROGESTERONE RECEPTOR)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	7 / 12	LEU A 766 ASN A 770 GLN A 776 MET A 807 ARG A 817 LEU A 848 CYH A 942	ECV  A1101 ( 3.9A) ECV  A1101 (-3.1A) ECV  A1101 (-2.9A) ECV  A1101 (-3.6A) ECV  A1101 (-4.0A) None ECV  A1101 (-4.0A)	0.89A	38.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3D90_A_NOGA1001_1 (PROGESTERONE RECEPTOR)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	8 / 12	LEU A 766 LEU A 769 ASN A 770 LEU A 772 GLN A 776 MET A 807 ARG A 817 CYH A 942	ECV  A1101 ( 3.9A) ECV  A1101 (-4.7A) ECV  A1101 (-3.1A) ECV  A1101 ( 3.9A) ECV  A1101 (-2.9A) ECV  A1101 (-3.6A) ECV  A1101 (-4.0A) ECV  A1101 (-4.0A)	0.56A	38.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3D90_A_NOGA1001_1 (PROGESTERONE RECEPTOR)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	5 / 12	LEU A 772 GLN A 776 MET A 807 ARG A 817 MET A 852	ECV  A1101 ( 3.9A) ECV  A1101 (-2.9A) ECV  A1101 (-3.6A) ECV  A1101 (-4.0A) ECV  A1101 (-3.7A)	1.11A	38.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D90_A_NOGA1001_1 (PROGESTERONE RECEPTOR)	5u77	OXYSTEROL-BINDING PROTEIN-RELATED PROTEIN 8 (Homo sapiens)	5 / 12	LEU A  72 LEU A 103 LEU A  98 GLN A  96 CYH A  69	None None NDB  A 201 (-4.3A) None None	1.31A	18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D90_A_NOGA1001_1 (PROGESTERONE RECEPTOR)	6el8	FORKHEAD BOX PROTEIN N1 (Homo sapiens)	5 / 12	LEU A 322 ASN A 321 LEU A 278 MET A 354 CYH A 327	None	1.32A	18.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D90_B_NOGB2001_1 (PROGESTERONE RECEPTOR)	1fch	PEROXISOMAL TARGETING SIGNAL 1 RECEPTOR (Homo sapiens)	5 / 12	LEU A 457 LEU A 460 LEU A 463 GLN A 382 LEU A 430	None	1.32A	21.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D90_B_NOGB2001_1 (PROGESTERONE RECEPTOR)	1xb7	STEROID HORMONE RECEPTOR ERR1 (Homo sapiens)	5 / 12	LEU A 324 LEU A 327 MET A 362 ARG A 372 LEU A 401	None	0.78A	26.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3D90_B_NOGB2001_1 (PROGESTERONE RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	6 / 12	LEU A 701 ASN A 705 LEU A 707 GLN A 711 MET A 742 ARG A 752	None BHM  A   1 (-3.6A) BHM  A   1 ( 4.2A) BHM  A   1 (-2.2A) BHM  A   1 ( 4.0A) BHM  A   1 (-3.8A)	0.70A	54.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3D90_B_NOGB2001_1 (PROGESTERONE RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	6 / 12	LEU A 704 ASN A 705 LEU A 707 GLN A 711 MET A 742 ARG A 752	BHM  A   1 (-4.0A) BHM  A   1 (-3.6A) BHM  A   1 ( 4.2A) BHM  A   1 (-2.2A) BHM  A   1 ( 4.0A) BHM  A   1 (-3.8A)	0.58A	54.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3D90_B_NOGB2001_1 (PROGESTERONE RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	5 / 12	LEU A 707 GLN A 711 MET A 742 ARG A 752 MET A 787	BHM  A   1 ( 4.2A) BHM  A   1 (-2.2A) BHM  A   1 ( 4.0A) BHM  A   1 (-3.8A) BHM  A   1 (-3.6A)	0.93A	54.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D90_B_NOGB2001_1 (PROGESTERONE RECEPTOR)	2gpv	ESTROGEN-RELATED RECEPTOR GAMMA (Homo sapiens)	6 / 12	LEU A 265 LEU A 268 LEU A 271 MET A 306 ARG A 316 LEU A 345	None OHT  A 500 (-4.1A) OHT  A 500 ( 4.4A) OHT  A 500 (-3.9A) OHT  A 500 (-3.8A) OHT  A 500 (-4.3A)	0.59A	28.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D90_B_NOGB2001_1 (PROGESTERONE RECEPTOR)	2ixm	SERINE/THREONINE-PRO TEIN PHOSPHATASE 2A REGULATORY SUBUNIT B' (Homo sapiens)	5 / 12	LEU A  80 LEU A  81 LEU A 189 ARG A 193 LEU A 163	None	1.27A	20.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D90_B_NOGB2001_1 (PROGESTERONE RECEPTOR)	2wgh	RIBONUCLEOSIDE-DIPHO SPHATE REDUCTASE LARGE SUBUNIT (Homo sapiens)	5 / 12	LEU A 527 ASN A 528 LEU A 526 LEU A 578 LEU A 466	None	1.31A	18.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D90_B_NOGB2001_1 (PROGESTERONE RECEPTOR)	3ahr	ERO1-LIKE PROTEIN ALPHA (Homo sapiens)	5 / 12	LEU A 343 LEU A 344 ASN A 340 LEU A 443 LEU A  65	None	1.17A	21.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D90_B_NOGB2001_1 (PROGESTERONE RECEPTOR)	3b2r	CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	5 / 12	LEU A 647 LEU A 644 LEU A 641 LEU A 595 MET A 590	None	1.32A	22.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D90_B_NOGB2001_1 (PROGESTERONE RECEPTOR)	3eap	RHO GTPASE-ACTIVATING PROTEIN 11A (Homo sapiens)	5 / 12	LEU A  15 LEU A  12 LEU A   9 LEU A 137 CYH A 161	None	1.18A	22.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3D90_B_NOGB2001_1 (PROGESTERONE RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	11 / 12	LEU A 715 LEU A 718 ASN A 719 LEU A 721 GLN A 725 MET A 756 LEU A 763 ARG A 766 MET A 801 TYR A 890 CYH A 891	WOW  A   1 (-3.9A) WOW  A   1 (-4.2A) WOW  A   1 (-3.3A) WOW  A   1 ( 4.3A) WOW  A   1 ( 4.1A) WOW  A   1 ( 4.1A) WOW  A   1 ( 4.0A) WOW  A   1 (-3.8A) WOW  A   1 (-4.2A) WOW  A   1 (-3.9A) WOW  A   1 (-3.5A)	0.55A	100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3D90_B_NOGB2001_1 (PROGESTERONE RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	7 / 12	LEU A 715 LEU A 721 MET A 756 LEU A 763 LEU A 797 TYR A 890 CYH A 891	WOW  A   1 (-3.9A) WOW  A   1 ( 4.3A) WOW  A   1 ( 4.1A) WOW  A   1 ( 4.0A) WOW  A   1 ( 4.5A) WOW  A   1 (-3.9A) WOW  A   1 (-3.5A)	0.72A	100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3D90_B_NOGB2001_1 (PROGESTERONE RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	5 / 12	LEU A 721 LEU A 718 LEU A 715 LEU A 763 MET A 801	WOW  A   1 ( 4.3A) WOW  A   1 (-4.2A) WOW  A   1 (-3.9A) WOW  A   1 ( 4.0A) WOW  A   1 (-4.2A)	1.21A	100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D90_B_NOGB2001_1 (PROGESTERONE RECEPTOR)	3kn5	RIBOSOMAL PROTEIN S6 KINASE ALPHA-5 (Homo sapiens)	5 / 12	LEU A 676 LEU A 667 LEU A 668 LEU A 687 MET A 525	None	1.30A	22.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D90_B_NOGB2001_1 (PROGESTERONE RECEPTOR)	3rw7	NUCLEAR RNA EXPORT FACTOR 1 (Homo sapiens)	5 / 12	LEU A 270 ASN A 271 LEU A 227 LEU A 257 MET A 283	None	1.33A	22.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D90_B_NOGB2001_1 (PROGESTERONE RECEPTOR)	4ay9	FOLLICLE-STIMULATING HORMONE RECEPTOR (Homo sapiens)	5 / 12	LEU X 177 ASN X 178 LEU X 200 LEU X 195 LEU X 148	None	1.29A	22.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D90_B_NOGB2001_1 (PROGESTERONE RECEPTOR)	4giw	RUN AND SH3 DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	5 / 12	LEU A 185 LEU A 128 ASN A 129 LEU A 127 LEU A 175	None	1.27A	22.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D90_B_NOGB2001_1 (PROGESTERONE RECEPTOR)	4i5j	SERINE/THREONINE-PRO TEIN PHOSPHATASE 2A REGULATORY SUBUNIT B'' SUBUNIT ALPHA (Homo sapiens)	5 / 12	LEU A 261 LEU A 258 LEU A 255 LEU A 184 LEU A 201	None	1.20A	22.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D90_B_NOGB2001_1 (PROGESTERONE RECEPTOR)	4keg	MALTOSE-BINDING PERIPLASMIC/PALATE LUNG AND NASAL EPITHELIUM CLONE FUSION PROTEIN (Escherichia coli; Homo sapiens)	5 / 12	LEU A1065 LEU A1068 LEU A1071 LEU A1157 LEU A1116	None	1.19A	16.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D90_B_NOGB2001_1 (PROGESTERONE RECEPTOR)	4oiv	BILE ACID RECEPTOR (Homo sapiens)	5 / 12	LEU A 422 LEU A 419 LEU A 416 GLN A 412 LEU A 441	None	1.21A	25.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3D90_B_NOGB2001_1 (PROGESTERONE RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	9 / 12	ASN A 564 LEU A 566 GLN A 570 MET A 601 LEU A 608 ARG A 611 MET A 646 TYR A 735 CYH A 736	MOF  A 801 (-3.0A) MOF  A 801 ( 4.6A) MOF  A 801 (-2.9A) MOF  A 801 (-3.7A) MOF  A 801 ( 4.6A) MOF  A 801 (-4.2A) MOF  A 801 (-4.4A) MOF  A 801 (-4.8A) MOF  A 801 (-3.7A)	0.63A	54.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3D90_B_NOGB2001_1 (PROGESTERONE RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	9 / 12	LEU A 563 ASN A 564 LEU A 566 GLN A 570 MET A 601 LEU A 608 ARG A 611 MET A 646 CYH A 736	MOF  A 801 (-3.9A) MOF  A 801 (-3.0A) MOF  A 801 ( 4.6A) MOF  A 801 (-2.9A) MOF  A 801 (-3.7A) MOF  A 801 ( 4.6A) MOF  A 801 (-4.2A) MOF  A 801 (-4.4A) MOF  A 801 (-3.7A)	0.65A	54.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3D90_B_NOGB2001_1 (PROGESTERONE RECEPTOR)	4udb	MINERALOCORTICOID RECEPTOR (Homo sapiens)	10 / 12	LEU A 766 LEU A 769 ASN A 770 LEU A 772 GLN A 776 MET A 807 LEU A 814 ARG A 817 LEU A 848 CYH A 942	CV7  A1987 (-3.6A) CV7  A1987 (-4.1A) CV7  A1987 (-3.1A) CV7  A1987 ( 4.5A) CV7  A1987 (-3.0A) CV7  A1987 ( 3.9A) CV7  A1987 ( 4.0A) CV7  A1987 (-3.7A) CV7  A1987 ( 4.4A) CV7  A1987 (-4.0A)	0.69A	52.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3D90_B_NOGB2001_1 (PROGESTERONE RECEPTOR)	4udb	MINERALOCORTICOID RECEPTOR (Homo sapiens)	10 / 12	LEU A 766 LEU A 769 ASN A 770 LEU A 772 GLN A 776 MET A 807 LEU A 814 ARG A 817 MET A 852 CYH A 942	CV7  A1987 (-3.6A) CV7  A1987 (-4.1A) CV7  A1987 (-3.1A) CV7  A1987 ( 4.5A) CV7  A1987 (-3.0A) CV7  A1987 ( 3.9A) CV7  A1987 ( 4.0A) CV7  A1987 (-3.7A) CV7  A1987 ( 3.7A) CV7  A1987 (-4.0A)	0.69A	52.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3D90_B_NOGB2001_1 (PROGESTERONE RECEPTOR)	4udb	MINERALOCORTICOID RECEPTOR (Homo sapiens)	6 / 12	LEU A 766 LEU A 769 ASN A 770 LEU A 827 LEU A 848 CYH A 942	CV7  A1987 (-3.6A) CV7  A1987 (-4.1A) CV7  A1987 (-3.1A) None CV7  A1987 ( 4.4A) CV7  A1987 (-4.0A)	1.47A	52.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D90_B_NOGB2001_1 (PROGESTERONE RECEPTOR)	5iy9	DNA-DIRECTED RNA POLYMERASE II SUBUNIT RPB1 (Homo sapiens)	5 / 12	LEU A1124 LEU A1127 LEU A1411 LEU A1401 MET A1405	None	1.26A	10.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3D90_B_NOGB2001_1 (PROGESTERONE RECEPTOR)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	9 / 12	LEU A 766 LEU A 769 ASN A 770 GLN A 776 MET A 807 LEU A 814 ARG A 817 LEU A 848 CYH A 942	ECV  A1101 ( 3.9A) ECV  A1101 (-4.7A) ECV  A1101 (-3.1A) ECV  A1101 (-2.9A) ECV  A1101 (-3.6A) ECV  A1101 (-4.1A) ECV  A1101 (-4.0A) None ECV  A1101 (-4.0A)	0.78A	38.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3D90_B_NOGB2001_1 (PROGESTERONE RECEPTOR)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	9 / 12	LEU A 766 LEU A 769 ASN A 770 LEU A 772 GLN A 776 MET A 807 LEU A 814 ARG A 817 CYH A 942	ECV  A1101 ( 3.9A) ECV  A1101 (-4.7A) ECV  A1101 (-3.1A) ECV  A1101 ( 3.9A) ECV  A1101 (-2.9A) ECV  A1101 (-3.6A) ECV  A1101 (-4.1A) ECV  A1101 (-4.0A) ECV  A1101 (-4.0A)	0.59A	38.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3D90_B_NOGB2001_1 (PROGESTERONE RECEPTOR)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	6 / 12	LEU A 772 GLN A 776 MET A 807 LEU A 814 ARG A 817 MET A 852	ECV  A1101 ( 3.9A) ECV  A1101 (-2.9A) ECV  A1101 (-3.6A) ECV  A1101 (-4.1A) ECV  A1101 (-4.0A) ECV  A1101 (-3.7A)	1.33A	38.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3D90_B_NOGB2001_1 (PROGESTERONE RECEPTOR)	5toa	ESTROGEN RECEPTOR BETA (Homo sapiens)	5 / 12	LEU A 298 LEU A 301 MET A 336 LEU A 343 ARG A 346	EST  A 601 (-4.1A) EST  A 601 ( 4.3A) EST  A 601 ( 3.7A) EST  A 601 ( 4.4A) EST  A 601 (-4.1A)	0.48A	30.43